why choose us

First received: April 17, 2023

Clinical Trial: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Community-acquired Pneumonia

Study Type: INTERVENTIONAL


Official Title: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Brief Summary: This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thromboprophylaxis on outcomes in patients admitted to hospital with community acquired pneumonia (CAP).

Read more